Two Sigma Investments, LP Lineage Cell Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$59 Billion
Q3 2025

A detailed history of Two Sigma Investments, LP transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 354,347 shares of LCTX stock, worth $673,259. This represents 0.0% of its overall portfolio holdings.

Number of Shares

354,347

Previous 317,977 11.44%

Holding current value

$673,259

Previous $289,000 112.11%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$0.87 - $1.79 $31,641 - $65,102	36,370 Added 11.44%	354,347 $613,000
Q2 2025 Aug 14, 2025	SELL	$0.39 - $1.13 $63,353 - $183,563	-162,446 Reduced 33.81%	317,977 $289,000
Q1 2025 May 15, 2025	BUY	$0.45 - $0.72 $80,495 - $128,792	178,879 Added 59.32%	480,423 $216,000
Q4 2024 Feb 14, 2025	BUY	$0.5 - $0.95 $150,772 - $286,466	301,544 New	301,544 $150,000
Q2 2023 Aug 14, 2023	BUY	$1.26 - $1.53 $71,202 - $86,460	56,510 Added 223.31%	81,816 $115,000

Q1 2023 May 15, 2023	SELL	$1.2 - $1.53 $6,427 - $8,194	-5,356 Reduced 17.47%	25,306 $37,000
Q4 2022 Feb 14, 2023	BUY	$1.02 - $1.5 $31,275 - $45,993	30,662 New	30,662 $35,000
Q1 2022 May 16, 2022	SELL	$1.21 - $2.48 $654,397 - $1.34 Million	-540,824 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.84 - $2.68 $73,533 - $107,103	-39,964 Reduced 6.88%	540,824 $1.33 Million
Q3 2021 Nov 15, 2021	SELL	$2.26 - $2.86 $1.66 Million - $2.1 Million	-733,779 Reduced 55.82%	580,788 $1.46 Million
Q2 2021 Aug 16, 2021	BUY	$2.17 - $3.0 $130,278 - $180,108	60,036 Added 4.79%	1,314,567 $3.75 Million
Q1 2021 May 17, 2021	BUY	$1.77 - $3.1 $1.25 Million - $2.19 Million	707,316 Added 129.26%	1,254,531 $2.95 Million
Q4 2020 Feb 16, 2021	BUY	$0.95 - $1.83 $320,349 - $617,094	337,210 Added 160.57%	547,215 $963,000
Q3 2020 Nov 16, 2020	SELL	$0.75 - $1.09 $89,202 - $129,640	-118,936 Reduced 36.16%	210,005 $197,000
Q2 2020 Aug 14, 2020	BUY	$0.71 - $1.18 $118,078 - $196,243	166,308 Added 102.26%	328,941 $286,000
Q1 2020 May 15, 2020	SELL	$0.6 - $1.58 $114,643 - $301,893	-191,072 Reduced 54.02%	162,633 $135,000
Q4 2019 Feb 14, 2020	BUY	$0.54 - $1.01 $11,129 - $20,816	20,610 Added 6.19%	353,705 $315,000
Q3 2019 Nov 14, 2019	BUY	$0.85 - $1.24 $283,130 - $413,037	333,095 New	333,095 $326,000

Others Institutions Holding LCTX

# of Institutions

128

Shares Held

96M

Call Options Held

251K

Put Options Held

50K

View Full List

About Lineage Cell Therapeutics, Inc.

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $323M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

More about LCTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Lineage Cell Therapeutics, Inc. Transaction History